scholarly journals Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer

Cell Cycle ◽  
2013 ◽  
Vol 13 (2) ◽  
pp. 199-207 ◽  
Author(s):  
Katherine M Aird ◽  
Hua Li ◽  
Frances Xin ◽  
Panagiotis A Konstantinopoulos ◽  
Rugang Zhang
2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 9673-9673
Author(s):  
J. A. Villella ◽  
F. Qian ◽  
B. Keitz ◽  
D. Driscoll ◽  
J. Skipper ◽  
...  

2007 ◽  
Vol 13 (5) ◽  
pp. 1421-1428 ◽  
Author(s):  
Manoj Garg ◽  
Dipak Chaurasiya ◽  
Ritu Rana ◽  
Nirmala Jagadish ◽  
Deepika Kanojia ◽  
...  

2020 ◽  
Vol 159 ◽  
pp. 346-347
Author(s):  
W.Y. Hwang ◽  
S.I. Kim ◽  
M. Lee ◽  
K. Kim ◽  
J.H. No ◽  
...  

2018 ◽  
Vol 39 (03) ◽  
pp. 180-186
Author(s):  
Ann-K. Langner ◽  
Nina Pauly ◽  
Beyhan Ataseven ◽  
Andreas du Bois

Die Behandlung des epithelialen Ovarial-, Tuben- und Peritonealkarzinoms (epithelial ovarian cancer; EOC) fußt auf 3 Säulen, die in unterschiedlichem Maße individualisierte bzw. personalisierte Medizin inkludieren:


2018 ◽  
Author(s):  
M Eberhardt ◽  
N Häfner ◽  
D Kritsch ◽  
M Rengsberger ◽  
M Dürst ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document